Malignant melanoma.
Schwartsmann
G
G
South American New Drug Development Office, Port Allegre, Brazil.
Parkinson
D R
DR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D008545:Melanoma / Q000188:drug therapy* / Q000503:physiopathology
D000970:Antineoplastic Agents; D007155:Immunologic Factors